Belinda Fazekas
Overview
Explore the profile of Belinda Fazekas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
392
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Razmovski-Naumovski V, Martin J, Chye R, Phillips J, Lintzeris N, Solowij N, et al.
J Pain Symptom Manage
. 2025 Feb;
PMID: 39988015
Context: Evaluating medicinal cannabis in clinical trials is important for informing its efficacy and safety in clinical care. Alongside the inherent practical challenges of conducting clinical trials in people receiving...
2.
Ferreira D, Ekstrom M, Bajwah S, Janssen D, Fazekas B, Currow D
Eur Respir J
. 2024 Jul;
64(1).
PMID: 38991720
No abstract available.
3.
Currow D, Fazekas B, Brown L, Kochovska S, Clark K, Agar M
J Palliat Med
. 2023 Oct;
27(1):93-98.
PMID: 37824800
To describe the harms in all arms of six consecutive multi-site, double-blind, placebo-controlled randomised clinical trials. Controversies surround conduct of phase III clinical trials in palliative care. Concerns include risks...
4.
Ferreira D, Ekstrom M, Bajwah S, Fazekas B, Currow D
Eur Respir J
. 2023 Sep;
62(3).
PMID: 37678949
No abstract available.
5.
Sousa M, Martin P, Johnson M, Lind M, Maddocks M, Bullock A, et al.
PLoS One
. 2023 May;
18(5):e0285850.
PMID: 37195996
Anorexia is experienced by most people with lung cancer during the course of their disease and treatment. Anorexia reduces response to chemotherapy and the ability of patients to cope with,...
6.
Lee J, Currow D, Lovell M, Phillips J, McLachlan A, Ritchie M, et al.
BMJ Open
. 2023 Feb;
13(2):e066125.
PMID: 36810169
Introduction: Many patients experience unrelieved neuropathic cancer-related pain. Most current analgesic therapies have psychoactive side effects, lack efficacy data for this indication and have potential medication-related harms. The local anaesthetic...
7.
Ekstrom M, Ferreira D, Chang S, Louw S, Johnson M, Eckert D, et al.
JAMA
. 2022 Nov;
328(20):2022-2032.
PMID: 36413230
Importance: Chronic breathlessness is common in people with chronic obstructive pulmonary disease (COPD). Regular, low-dose, extended-release morphine may relieve breathlessness, but evidence about its efficacy and dosing is needed. Objective:...
8.
Ferreira D, Ekstrom M, Fazekas B, Currow D
J Palliat Med
. 2022 Nov;
26(3):402-405.
PMID: 36394475
The intermediate- and long-term effects of regular low-dose sustained-release (SR) morphine on the testosterone levels of people with persistent breathlessness are unknown. Exploratory analysis of a randomized controlled trial of...
9.
Matsuoka H, Clark K, Fazekas B, Oyamada S, Brown L, Ishiki H, et al.
BMJ Open
. 2022 Feb;
12(2):e050182.
PMID: 35131817
Introduction: Management of neuropathic cancer pain (NCP) refractory to regular opioids remains an important challenge. The efficacy of pregabalin for NCP except chemotherapy-induced peripheral neuropathy (CIPN) has already been confirmed...
10.
Butcher B, Hutchings E, Fazekas B, Clark K, Rowett D, Currow D
Palliat Med
. 2021 Oct;
36(1):71-80.
PMID: 34633250
Background: Standard of care in treatment of cancer-related pain involves opioids in combination with non-steroidal anti-inflammatory drugs (NSAID). Ketorolac, a NSAID, has demonstrated opioid-sparing effects in other clinical settings. Aim:...